MedPath

Potassium-competitive acid blocker-based third-line triple therapy in Helicobacter Pylori eradicatio

Not Applicable
Conditions
chronic gastritis with H.Pylori infection
Registration Number
JPRN-UMIN000025252
Lead Sponsor
Kochi medical school
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

< 20 years old Patients with severe heart desease, renal dysfunction or liver dysfunction Patients with allergy for 3rd-eradication drugs Patients using anti-coagulation or anti-platelet drugs Pregnants or patient who want pregnancy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
the antimicrobial susceptibility test and eradication rate after 8weeks
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath